Literature DB >> 22439936

Marginating dendritic cells of the tumor microenvironment cross-present tumor antigens and stably engage tumor-specific T cells.

John J Engelhardt1, Bijan Boldajipour, Peter Beemiller, Priya Pandurangi, Caitlin Sorensen, Zena Werb, Mikala Egeblad, Matthew F Krummel.   

Abstract

The nature and site of tumor-antigen presentation to immune T cells by bone-marrow-derived cells within the tumor microenvironment remains unresolved. We generated a fluorescent mouse model of spontaneous immunoevasive breast cancer and identified a subset of myeloid cells with significant similarity to dendritic cells and macrophages that constitutively ingest tumor-derived proteins and present processed tumor antigens to reactive T cells. Using intravital live imaging, we determined that infiltrating tumor-specific T cells engage in long-lived interactions with these cells, proximal to the tumor. In vitro, these cells capture cytotoxic T cells in signaling-competent conjugates but do not support full activation or sustain cytolysis. The spatiotemporal dynamics revealed here implicate nonproductive interactions between T cells and antigen-presenting cells on the tumor margin. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22439936      PMCID: PMC3311997          DOI: 10.1016/j.ccr.2012.01.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  49 in total

1.  T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases.

Authors:  Thorsten R Mempel; Sarah E Henrickson; Ulrich H Von Andrian
Journal:  Nature       Date:  2004-01-08       Impact factor: 49.962

2.  S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis.

Authors:  K Ambe; M Mori; M Enjoji
Journal:  Cancer       Date:  1989-02-01       Impact factor: 6.860

Review 3.  MUC-1 epithelial tumor mucin-based immunity and cancer vaccines.

Authors:  O J Finn; K R Jerome; R A Henderson; G Pecher; N Domenech; J Magarian-Blander; S M Barratt-Boyes
Journal:  Immunol Rev       Date:  1995-06       Impact factor: 12.988

4.  Serial triggering of many T-cell receptors by a few peptide-MHC complexes.

Authors:  S Valitutti; S Müller; M Cella; E Padovan; A Lanzavecchia
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

5.  A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

Authors:  P van der Bruggen; C Traversari; P Chomez; C Lurquin; E De Plaen; B Van den Eynde; A Knuth; T Boon
Journal:  Science       Date:  1991-12-13       Impact factor: 47.728

6.  Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor.

Authors:  Y Kawakami; S Eliyahu; C H Delgado; P F Robbins; L Rivoltini; S L Topalian; T Miki; S A Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

7.  Split anergy in a CD8+ T cell: receptor-dependent cytolysis in the absence of interleukin-2 production.

Authors:  G R Otten; R N Germain
Journal:  Science       Date:  1991-03-08       Impact factor: 47.728

8.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.

Authors:  C T Guy; R D Cardiff; W J Muller
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

9.  Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.

Authors:  J I Mayordomo; T Zorina; W J Storkus; L Zitvogel; C Celluzzi; L D Falo; C J Melief; S T Ildstad; W M Kast; A B Deleo
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

10.  Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

Authors:  Masaki Terabe; So Matsui; Jong-Myun Park; Mizuko Mamura; Nancy Noben-Trauth; Debra D Donaldson; Wanjun Chen; Sharon M Wahl; Steven Ledbetter; Bruce Pratt; John J Letterio; William E Paul; Jay A Berzofsky
Journal:  J Exp Med       Date:  2003-12-01       Impact factor: 14.307

View more
  154 in total

Review 1.  The immunological synapse.

Authors:  Michael L Dustin
Journal:  Cancer Immunol Res       Date:  2014-11       Impact factor: 11.151

Review 2.  TGFβ biology in cancer progression and immunotherapy.

Authors:  Rik Derynck; Shannon J Turley; Rosemary J Akhurst
Journal:  Nat Rev Clin Oncol       Date:  2020-07-24       Impact factor: 66.675

3.  TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer.

Authors:  Álvaro de Mingo Pulido; Alycia Gardner; Shandi Hiebler; Hatem Soliman; Hope S Rugo; Matthew F Krummel; Lisa M Coussens; Brian Ruffell
Journal:  Cancer Cell       Date:  2018-01-08       Impact factor: 31.743

4.  Medical imaging: Removing the blindfold.

Authors:  Katherine Bourzac
Journal:  Nature       Date:  2013-12-19       Impact factor: 49.962

5.  Spectrum- and time-resolved endogenous multiphoton signals reveal quantitative differentiation of premalignant and malignant gastric mucosa.

Authors:  Xi Li; Hui Li; Xingzhen He; Tingai Chen; Xianyuan Xia; Chunxia Yang; Wei Zheng
Journal:  Biomed Opt Express       Date:  2018-01-08       Impact factor: 3.732

6.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

7.  Oxidized lipids block antigen cross-presentation by dendritic cells in cancer.

Authors:  Rupal Ramakrishnan; Vladimir A Tyurin; Vladimir A Tuyrin; Filippo Veglia; Thomas Condamine; Andrew Amoscato; Dariush Mohammadyani; Joseph J Johnson; Lan Min Zhang; Judith Klein-Seetharaman; Esteban Celis; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2014-02-19       Impact factor: 5.422

Review 8.  Regulatory circuits of T cell function in cancer.

Authors:  Daniel E Speiser; Ping-Chih Ho; Grégory Verdeil
Journal:  Nat Rev Immunol       Date:  2016-08-16       Impact factor: 53.106

9.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.

Authors:  Jonathan B Mitchem; Donal J Brennan; Brett L Knolhoff; Brian A Belt; Yu Zhu; Dominic E Sanford; Larisa Belaygorod; Danielle Carpenter; Lynne Collins; David Piwnica-Worms; Stephen Hewitt; Girish Mallya Udupi; William M Gallagher; Craig Wegner; Brian L West; Andrea Wang-Gillam; Peter Goedegebuure; David C Linehan; David G DeNardo
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

10.  Tumor-infiltrating lymphocytes are dynamically desensitized to antigen but are maintained by homeostatic cytokine.

Authors:  Bijan Boldajipour; Amanda Nelson; Matthew F Krummel
Journal:  JCI Insight       Date:  2016-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.